Reminyl 16 mg prolonged-release capsules

Reminyl is a pharmaceutical product containing galantamine, primarily used for the treatment of mild to moderate dementia of the Alzheimer's type. The brand was originally developed by Janssen Pharmaceutica, a company founded in Belgium that later became a subsidiary of the American multinational Johnson & Johnson.

Today, the rights and ownership of Reminyl vary by region due to strategic pharmaceutical divestments. In many European markets, including Spain (as indicated by the packaging), the brand is managed or owned by Essential Pharma. Manufacturing typically takes place in specialized pharmaceutical facilities in Belgium or other EU locations to ensure strict compliance with medical standards. The product remains a cornerstone in cognitive therapy, providing a sustained release of its active ingredient to improve nerve cell function in the brain.